- Home
- BCRX vs CUBI Comparison
BCRX vs CUBI Comparison
Compare BCRX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CUBI
- Stock Information
- Founded
- BCRX 1986
- CUBI 1994
- Country
- BCRX United States
- CUBI United States
- Employees
- BCRX N/A
- CUBI N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CUBI Major Banks
- Sector
- BCRX Health Care
- CUBI Finance
- Exchange
- BCRX Nasdaq
- CUBI Nasdaq
- Market Cap
- BCRX 1.7B
- CUBI 1.6B
- IPO Year
- BCRX 1994
- CUBI 2012
- Fundamental
- Price
- BCRX $7.86
- CUBI $50.14
- Analyst Decision
- BCRX Buy
- CUBI Buy
- Analyst Count
- BCRX 6
- CUBI 10
- Target Price
- BCRX $15.67
- CUBI $65.67
- AVG Volume (30 Days)
- BCRX 3.6M
- CUBI 284.8K
- Earning Date
- BCRX 05-05-2025
- CUBI 04-24-2025
- Dividend Yield
- BCRX N/A
- CUBI N/A
- EPS Growth
- BCRX N/A
- CUBI N/A
- EPS
- BCRX N/A
- CUBI 5.09
- Revenue
- BCRX $450,712,000.00
- CUBI $641,387,000.00
- Revenue This Year
- BCRX $27.66
- CUBI $13.03
- Revenue Next Year
- BCRX $13.59
- CUBI $9.70
- P/E Ratio
- BCRX N/A
- CUBI $9.85
- Revenue Growth
- BCRX 36.00
- CUBI N/A
- 52 Week Low
- BCRX $4.03
- CUBI $42.31
- 52 Week High
- BCRX $9.50
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- BCRX 46.95
- CUBI 41.73
- Support Level
- BCRX $7.44
- CUBI $50.60
- Resistance Level
- BCRX $8.12
- CUBI $53.95
- Average True Range (ATR)
- BCRX 0.27
- CUBI 1.54
- MACD
- BCRX 0.03
- CUBI 0.19
- Stochastic Oscillator
- BCRX 71.74
- CUBI 40.84
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.